Effects of Lepidium Meyenii Walp on Sexual Function in Postmenopausal Women (maca)
Sexual Dysfunction, Physiological
About this trial
This is an interventional treatment trial for Sexual Dysfunction, Physiological focused on measuring Sexual Dysfunction, Postmenopausal women, Sexual desire
Eligibility Criteria
Inclusion Criteria:
- The postmenopausal women with full autonomy, with one year or more of amenorrhea and follicle stimulating hormone (FSH) > 30 milli-International unit/mL
- Women who are not regularly practicing sexual activity will be included because the desire domain is subject to the same evaluation in this situation
- Estrogen and progesterone were permitted if the dose had been stable for six months prior to screening
Exclusion Criteria:
- Cardiac, renal and hepatic diseases
- Diabetes mellitus
- Cognitive disorders
- Hormone-dependent tumor
- History of psychiatric illness current and/or past, regular use of two or more doses of alcohol by day (dose = 12 grams of pure alcohol, which corresponds to 330 mL of beer, 100 mL wine, 30 mL of distilled World Health Organization standard dose) leading to impairment or clinically significant distress (DSM-5)
- Consumption of Maca supplements or any other nutritional supplement known to cause changes in sexual function
- Use of any drug that, in the opinion of the investigator, may affect sexual function or any of the following medications: anti-epileptics, cytochrome P450 isoform 3A4 (CYP3A4) inducers
- Dopamine agonists and other parkinsonian drugs
- Metoclopramide
- Androgens and antiandrogens, the anti-oestrogens
- Fluoxetine or any hormonal implant long-acting in 30 days before the exam
- Analogues of gonadotropin-releasing hormone and other hormones and inhibitors
- Benzodiazepines prescribed for insomnia
- Sedatives and hypnotics
- Antidepressants
- Antipsychotics, mood stabilizers, narcotics (except when used to relieve short-term pain),
- Lubricants/moisturizers that contain substances that promote heating and/or vaginal stimulators
Sites / Locations
- Vale Do Sapucai University (Univas)Recruiting
Arms of the Study
Arm 1
Arm 2
Placebo Comparator
Experimental
Placebo Group
Maca (Lepidium Meyenii Walp) Group
The effects of Placebo on sexual function, desire and depression in postmenopausal women. The Female Sexual Function Index (FSFI) and the Female Intervention Efficacy Index Questionnaire (FIEI). The Beck Depression Inventory II will be used to ward off depression
The effects of Lepidium Meyenii Walp on sexual function, desire and depression in postmenopausal women. The Female Sexual Function Index (FSFI) and the Female Intervention Efficacy Index Questionnaire (FIEI). The Beck Depression Inventory II will be used to ward off depression